ADMA Biologics (ADMA)
(Delayed Data from NSDQ)
$13.58 USD
-0.18 (-1.31%)
Updated Jul 24, 2024 04:00 PM ET
After-Market: $13.73 +0.15 (1.10%) 7:58 PM ET
1-Strong Buy of 5 1
F Value A Growth D Momentum C VGM
Price, Consensus and EPS Surprise
ADMA 13.58 -0.18(-1.31%)
Will ADMA be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for ADMA based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for ADMA
Adma Biologics (ADMA) Stock Moves -1.31%: What You Should Know
What's in Store for ADMA Biologics (ADMA) in Q2 Earnings?
ADMA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Adma Biologics (ADMA) Declines More Than Market: Some Information for Investors
Is First Trust Small Cap Growth AlphaDEX ETF (FYC) a Strong ETF Right Now?
Zacks.com featured highlights include ADMA Biologics, American Superconductor, biote, Lincoln Educational Services and Corcept Therapeutics
Other News for ADMA
Jim Cramer Recommends Not Selling Vertiv, Says Buy This Social Media Stock 'Hand Over Fist'
Leslie's Issues Preliminary Financial Results, Joins Beyond Meat, Domino's And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Peeling Back The Layers: Exploring ADMA Biologics Through Analyst Insights
Adma Biologics price target raised by $2 at Mizuho, here's why
Wall Street Breakfast: The Week Ahead